Unfavorable Demographics Tied to Heart Risk Factors in Asian Americans
By Elana Gotkine HealthDay Reporter
WEDNESDAY, April 3, 2024 -- Unfavorable social determinants of health (SDOH) are associated with higher odds of cardiovascular risk factors among Asian Americans, according to a study published online April 3 in the Journal of the American Heart Association.
Alicia L. Zhu, from the Stanford University Center for Asian Healthcare Research and Education in California, and colleagues used the National Health Interview Survey for 2013 to 2018 to examine SDOH associations with cardiovascular risk factors among Asian American subgroups. By categorizing 27 SDOH variables as 0 (favorable) or 1 (unfavorable), an SDOH score was created.
Data were included for 6,395 Asian adults aged 18 years and older (22.1, 21.6, 21.0, and 35.3 percent self-identified as Filipino, Asian Indian, Chinese, and other Asian, respectively). The researchers found that each standard deviation increment of SDOH score was associated with increased odds of diabetes among Chinese and Filipino adults (odds ratios, 1.45 and 1.24, respectively); high blood pressure among Filipino adults (odds ratio, 1.28); insufficient physical activity among Asian Indian, Chinese, and Filipino adults (odds ratios, 1.42, 1.58, and 1.24, respectively); suboptimal sleep among Asian Indian adults (odds ratio, 1.20); and nicotine exposure among Chinese and Filipino adults (odds ratios, 1.56 and 1.50, respectively).
"Despite the perception that Asian Americans may have lower SDOH scores or be less impacted by SDOH compared with other racial/ethnic groups, our findings indicate that unfavorable SDOH profiles are associated with higher prevalence of cardiovascular risk factors among Asian Americans," the authors write.
Several authors disclosed ties to the biopharmaceutical and medical technology industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.